Concepedia

Publication | Open Access

Primary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC)

DOIFull Paper Access

23

Citations

0

References

2017

Year

Silvia Novello, Julien Mazières, In‐Jae Oh, Javier de Castro, M.R. Migliorino, Åslaug Helland, Rafał Dziadziuszko, Frank Griesinger, Ahmed Kotb, A. Zeiter,
Annals of Oncology

No additional data available for this publication yet. Check back later!